(1-ll) were synthesized and evaluated for their inhibitory activity against pig kidney aldose reductase (EC 1, 1, 1, 21) . Of these compounds, AL2-p-hydroxyphenylethyl maleamic acid (10) exhibits the strongest aldose reductase inhibitory activity, which is 22 times more potent than that ofYUA001 1}.
Aldose reductase (AR) (EC 1, 1, 1, 21) is an NADPHspecific aldehyde reductase to catalyze the conversion of glucose to sorbitol in the polyol pathway2), and knownto be involved in the onset of secondary diabetic complications such as cataract, neuropathy, retinopathy and nephropathy3~5). In a previous paper1}, Bahn et Preparation of A^-substituted Tyramine Derivatives mlz 221 (M+).
Tyramine framework was modified as follows ( Fig. 1.) . iV-Pentanoyl Tyramine (2) The procedure was same as that of 1. 7V-Hexadecanoyl Tyramine (6) The procedure was same as that of 4. 
JV-Ethanoyl

COCH2(C//2)13CH3), 8 0.86 (3H, t, CO(CH2)14Ctf3); ESI-MS miz 375 (M+).
N-Benzoyl Tyramine (7) The procedure was same as that of 4. (10) showed the strongest AR inhibitory activity with an IC50 value of 8.04X 10~5 M, which is much lower than 1.80X l(T3 M ofYUA001 (Table 1) .
Disussion
We were interested in the amide moiety of YUA001, which might be the essential portion to have AR inhibitory activity, and modified it with the elongation of aliphatic chain (1) (2) (3) (4) (5) (6) as well as introducing the aromatic rings (7) (8) or terminal carboxyl acids (9-ll) . All the derivatives (1-ll) were found to have stronger activity than that of YUA001, but the chain length of acyl moiety did not affect their inhibitory activity significantly, JV-ethanoyl tyramine (1) N-pentanoyl tyramine (2) JV-octanoyl tyramine (3) JV-decanoyl tyramine (4) JV-dodecanoyl tyramine (5) iV-hexadecanoyl tyramine (6) Af-benzoyl tyramine ( Table 1 . In these compounds, N-2-phydroxyphenylethyl maleamic acid (10) exhibited the most potent activity, which is comparable to that of tolrestat. Further studies to find out the inhibitory mechanism of these derivatives (1-ll) and enhance their activities are underway.
2) Chihiro, Y N.: Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharm. Quantitative histochemistry of the sorbitol pathway in OCT. 2001 glomeruli and small orteries of human diabetic kidney.
